WealthTrust Axiom LLC Buys 194 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

WealthTrust Axiom LLC lifted its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 5.1% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 4,027 shares of the company’s stock after purchasing an additional 194 shares during the quarter. WealthTrust Axiom LLC’s holdings in GE HealthCare Technologies were worth $311,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Chicago Capital LLC raised its stake in shares of GE HealthCare Technologies by 2.8% during the 3rd quarter. Chicago Capital LLC now owns 6,081 shares of the company’s stock valued at $414,000 after purchasing an additional 163 shares during the period. Chilton Capital Management LLC raised its stake in shares of GE HealthCare Technologies by 15.4% during the 4th quarter. Chilton Capital Management LLC now owns 1,227 shares of the company’s stock valued at $95,000 after purchasing an additional 164 shares during the period. Procyon Advisors LLC raised its stake in shares of GE HealthCare Technologies by 5.2% during the 4th quarter. Procyon Advisors LLC now owns 3,555 shares of the company’s stock valued at $275,000 after purchasing an additional 175 shares during the period. Meeder Advisory Services Inc. raised its stake in shares of GE HealthCare Technologies by 5.4% during the 4th quarter. Meeder Advisory Services Inc. now owns 3,634 shares of the company’s stock valued at $281,000 after purchasing an additional 185 shares during the period. Finally, Forum Financial Management LP raised its stake in shares of GE HealthCare Technologies by 3.9% during the 3rd quarter. Forum Financial Management LP now owns 4,989 shares of the company’s stock valued at $339,000 after purchasing an additional 186 shares during the period. 82.06% of the stock is currently owned by institutional investors.

GE HealthCare Technologies Trading Down 14.3 %

Shares of GEHC stock opened at $76.24 on Wednesday. The stock has a market capitalization of $34.79 billion, a PE ratio of 25.25, a P/E/G ratio of 3.09 and a beta of 0.94. GE HealthCare Technologies Inc. has a 1-year low of $62.35 and a 1-year high of $94.50. The business has a 50-day moving average of $88.98 and a 200 day moving average of $78.75. The company has a debt-to-equity ratio of 1.18, a current ratio of 1.05 and a quick ratio of 0.83.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Tuesday, April 30th. The company reported $0.90 earnings per share for the quarter, meeting the consensus estimate of $0.90. The company had revenue of $4.65 billion during the quarter, compared to analysts’ expectations of $4.80 billion. GE HealthCare Technologies had a return on equity of 25.58% and a net margin of 8.02%. GE HealthCare Technologies’s quarterly revenue was down 1.2% compared to the same quarter last year. During the same period in the prior year, the business posted $0.85 EPS. As a group, sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be issued a $0.03 dividend. This represents a $0.12 annualized dividend and a yield of 0.16%. The ex-dividend date is Thursday, April 18th. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.97%.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on GEHC shares. Morgan Stanley upped their target price on GE HealthCare Technologies from $74.00 to $86.00 and gave the stock an “equal weight” rating in a research note on Monday, February 12th. Evercore ISI upped their target price on GE HealthCare Technologies from $93.00 to $100.00 and gave the stock an “outperform” rating in a research note on Thursday, April 4th. HSBC started coverage on GE HealthCare Technologies in a research note on Thursday, February 15th. They issued a “buy” rating and a $100.00 target price on the stock. Mizuho upped their target price on GE HealthCare Technologies from $96.00 to $110.00 and gave the stock a “buy” rating in a research note on Thursday, April 11th. Finally, Argus upped their target price on GE HealthCare Technologies from $80.00 to $110.00 and gave the stock a “buy” rating in a research note on Monday, April 1st. Four research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and a consensus price target of $95.09.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.